Atrial fibrillation trials in Netherlands
40 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleStroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
- Where
- Amsterdam
- Age
- 18 years and over
- People
- 2,628 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT07430956 · EU 2025-521618-25-00 - No phaseNot yet taking people in NetherlandsAlert-HF: Early Detection and Intervention on Atrial Fibrillation in Heart Failure Patients
- Where
- Enschede
- Age
- 18 years and over
- People
- 266
- Run by
- Medisch Spectrum Twente
See details and how to joinNCT07816458 - No phaseTaking peopleAI-Based Tools for Stroke Diagnosis, Treatment and Outcome Prediction: a Multicentre Prospective Observational Study
- Where
- Amsterdam, Rotterdam
- Age
- 18 years and over
- People
- 10,000 worldwide
- Run by
- Hospital Universitari Vall d'Hebron Research Institute
See details and how to joinNCT07924371 - Phase 3Taking peopleStroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
- Where
- Amersfoort, Amstelveen, Amsterdam, Apeldoorn, Arnhem, Deventer, Dirksland, Doetinchem, Ede Gld, Groningen, Hardenberg, Harderwijk, Heerlen, Leiderdorp, Roosendaal, Rotterdam, Sneek, Tilburg, Zwolle
- Age
- 18 years and over
- People
- 15,364 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT07626411 · EU 2025-521617-97-00 - Phase 2Taking peopleA Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of PKN605 in Participants With Atrial Fibrillation
- Where
- Arnhem, Delft, Goes, Groningen, Maastricht, Veldhoven
- Age
- 18 years and over
- People
- 165 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07217067 - Phase 2Taking peopleA Study to Test How Well BAY 3670549 Works and How Safe it is in Patients With Atrial Fibrillation
- Where
- Groningen, Maastricht
- Age
- 18 years to 85 years
- People
- 360 worldwide
- Run by
- Bayer
See details and how to joinNCT07625215 · EU 2025-523807-31-00 - No phaseTaking peopleThe Multicenter Cardiology Monitoring Platform Registry
- Where
- Maastricht
- Age
- 16 years and over
- People
- 40,000
- Run by
- Maastricht University Medical Center
See details and how to joinNCT04976348 - No phaseTaking peoplePulseSelect™ PFA Global Registry
- Where
- Nieuwegein
- Age
- 18 years and over
- People
- 1,950 worldwide
- Run by
- Medtronic Cardiac Ablation Solutions
See details and how to joinNCT06393920 - Phase 2Taking peopleA study to investigate the efficacy, safety, tolerability and pharmacokinetics of PKN605 in participants with atrial fibrillation
- Where
- Arnhem, Delft, Goes, Groningen, Haarlem, Maastricht, Veldhoven
- Age
- 18 years and over
- People
- 41 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2025-520518-79-00 · EU 2025-520518-79-00 - Phase 3Taking peopleReVeRA-301: Etripamil in Atrial Fibrillation Phase 3
- Where
- Alkmaar, Almelo, Amstelveen, Apeldoorn, Arnhem, Beverwijk, Breda, Dirksland, Ede, Groningen, Hardenberg, Heerenveen, Heerlen, Helmond, Leeuwarden, Roosendaal, Rotterdam, 'S-Hertogenbosch
- Age
- 18 years and over
- People
- 750 worldwide
- Run by
- Milestone Pharmaceuticals Inc.
See details and how to joinNCT06716021 · EU 2024-516251-40-01 - Phase 2Taking peopleClinical Phase 2 Trial of AP31969 Versus Placebo for Rhythm Control of Atrial Fibrillation
- Where
- Arnhem, Deventer, Groningen, Haarlem, Leeuwarden, Maastricht, 's-Gravenhage, Tiel, Veldhoven
- Age
- 18 years and over
- People
- 200 worldwide
- Run by
- Acesion Pharma
See details and how to joinNCT07267949 · EU 2025-521377-14-00 - No phaseTaking peopleThe Fourth Left Atrial Appendage Occlusion Study
- Where
- Eindhoven, Nieuwegein
- Age
- 18 years and over
- People
- 4,000 worldwide
- Run by
- Hamilton Health Sciences Corporation
See details and how to joinNCT05963698 - No phaseNot yet taking people in NetherlandsLattice vs Pentaspline Comparative Evaluation in Persistent AF
- Where
- Rotterdam
- Age
- 18 years and over
- People
- 250 worldwide
- Run by
- Mitera Hospital
See details and how to joinNCT07815171 - No phaseTaking peopleDetection of Atrial Fibrillation Using PPG From Smartphone Cameras
- Where
- Zwolle
- Age
- 22 Minutes and over
- People
- 554 worldwide
- Run by
- Happitech BV
See details and how to joinNCT07779213 - No phaseTaking peopleCoherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation
- Where
- Nieuwegein
- Age
- 18 years to 80 years
- People
- 360 worldwide
- Run by
- Arga Medtech SA
See details and how to joinNCT06784466 - No phaseTaking peopleOptimized Expansion of the Implanted Transcatheter Aortic Valve
- Where
- Amsterdam, Groningen, Leiden, Nieuwegein
- Age
- 18 years and over
- People
- 1,010 worldwide
- Run by
- Ole De Backer
See details and how to joinNCT07042529 - Phase 3Taking peopleSACK
- Where
- Nieuwegein
- Age
- 18 years and over
- People
- 1,281 worldwide
- Run by
- Karolinska University Hospital
See details and how to join2022-501600-10-00 · EU 2022-501600-10-00 - No phaseTaking peopleComparison Between Direct Oral Anticoagulation (DOAC) Interruption and DOAC Continuation in Patients Undergoing Elective Invasive Coronary Angiography or Percutaneous Coronary Intervention
- Where
- Heerlen
- Age
- 18 years and over
- People
- 1,270
- Run by
- Zuyderland Medisch Centrum
See details and how to joinNCT04977076 - No phaseNot yet taking people in NetherlandsAV Nodal Ablation With Conduction System Pacing Versus Cardiac Resynchronization for Symptomatic Heart Failure Patients With Atrial Fibrillation
- Where
- Groningen, Leeuwarden, Maastricht, Nieuwegein, 's-Hertogenbosch
- Age
- 18 years and over
- People
- 292 worldwide
- Run by
- University Medical Center Groningen
See details and how to joinNCT07604727 - No phaseTaking peoplePersonalized, CT-guided Antithrombotic Therapy Versus Lifelong Single Antiplatelet Therapy to Reduce Thromboembolic and Bleeding Events in Non-atrial Fibrillation Patients After Transcatheter Aortic Valve Implantation
- Where
- Nieuwegein
- Age
- 18 years to 110 years
- People
- 2,500
- Run by
- St. Antonius Hospital
See details and how to joinNCT06168370 - Phase 3Taking peopleEarly Treatment of Atrial Fibrillation for Stroke Prevention Trial in Acute STROKE
- Where
- Amsterdam, Nijmegen, 's-Gravenhage, Utrecht
- Age
- 18 years and over
- People
- 1,746 worldwide
- Run by
- Universitätsklinikum Hamburg-Eppendorf
See details and how to joinNCT05293080 · EU 2025-521260-35-00 - Phase 4Taking peopleMonotherapy With P2Y12 Inhibitors in Patients With Atrial fIbrillation Undergoing Supraflex Stent Implantation
- Where
- Amsterdam
- Age
- 18 years and over
- People
- 3,010 worldwide
- Run by
- Insel Gruppe AG, University Hospital Bern
See details and how to joinNCT05955365 - No phaseTaking peopleThe MAGiC™ Cardiac Ablation European Study
- Where
- Rotterdam
- Age
- 18 years and over
- People
- 150 worldwide
- Run by
- Stereotaxis
See details and how to joinNCT06019845 - Phase 4Taking peopleAnticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress
- Where
- Alkmaar, Almelo, Amstelveen, Arnhem, Breda, Deventer, Ede, Groningen, Rotterdam, 's-Hertogenbosch, Tilburg
- Age
- 55 years and over
- People
- 2,270 worldwide
- Run by
- Population Health Research Institute
See details and how to joinNCT03968393 · EU 2023-509142-35-00 - No phaseTaking peopleCellFX® nsPFA™ Cardiac Surgery System to Treat Atrial Fibrillation
- Where
- Amsterdam, Eindhoven, Maastricht, Nieuwegein
- Age
- 18 years to 85 years
- People
- 30 worldwide
- Run by
- Pulse Biosciences, Inc.
See details and how to joinNCT06355063